Research-Grade Tadalafil for Laboratory Applications
Tadalafil is a phosphodiesterase-5 (PDE5) inhibitor originally developed for cardiovascular research applications. This pharmaceutical-grade compound offers laboratories access to high-purity material specifically manufactured for in-vitro research protocols. Research institutions investigating vascular function, smooth muscle physiology, and nitric oxide signalling pathways frequently examine tadalafil’s mechanism of action as a selective PDE5 inhibitor. The compound’s well-characterised pharmacological profile makes it valuable for cardiovascular biology studies. Stroid UK Shop studying erectile dysfunction mechanisms appreciate tadalafil’s long half-life and tissue selectivity compared to other PDE inhibitors.
Experimental Research Applications
Laboratory studies frequently investigate tadalafil’s selective inhibition of phosphodiesterase-5, which prevents cyclic guanosine monophosphate (cGMP) degradation in vascular smooth muscle cells. Research demonstrates that tadalafil exhibits superior selectivity for PDE5 over other phosphodiesterase enzymes, making it particularly useful for investigating nitric oxide-cGMP signalling pathways. Cardiovascular researchers examine how tadalafil enhances nitric oxide-mediated vasodilation in various tissue models. Urological research applications include studies on penile vascular function and smooth muscle relaxation mechanisms. Scientists also investigate tadalafil’s potential effects on pulmonary arterial pressure in experimental models. Research-grade materials enable consistent experimental conditions across multiple study protocols.
Technical Specifications
| Chemical Name | Tadalafil |
|---|---|
| CAS Number | 171596-29-5 |
| Molecular Formula | C₂₂H₁₉N₃O₄ |
| Molecular Weight | 389.40 g/mol |
| Purity | ≥98% (verified by supplier) |
| Solubility | DMSO, ethanol, limited aqueous |
| Storage | Room temperature, dry, protected from light |
Laboratory studies benefit from tadalafil’s chemical stability and well-defined solubility characteristics. The compound’s favourable pharmacokinetic properties in research models include excellent oral bioavailability and extended tissue residence time compared to other PDE5 inhibitors. Research laboratories examining vascular biology often compare tadalafil’s effects with other compounds. Quality control protocols ensure consistent molecular structure and purity across research batches. Scientific investigations requiring reproducible results depend on pharmaceutical-grade materials meeting strict analytical standards.
Research Compliance Statement
This tadalafil preparation is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. The compound is not intended for human consumption, veterinary applications, or therapeutic use of any kind. Research institutions must ensure appropriate safety protocols, waste disposal procedures, and regulatory compliance when handling this material. Laboratory personnel should consult relevant safety data sheets and institutional guidelines before experimental use.
